Lo, Serigne N <br/><br/>
Reply to M. Horiguchi et al.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  03 2018 
 - 722-723 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2017.76.5347  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Humans<br/>Ipilimumab<br/>Melanoma<br/>Nivolumab